retatrutide mechanism of action triple agonist glp-1 gip glucagon Retatrutide: How the Compares to Tirzepatide GLP-1-based therapies for type 2
Description
Understanding GLP-1: What Are These Medications
Relative to placebo, the reduction of diastolic BP only reached significance for the treatment of exenatide 10 g/twice daily (1.08 mmHg) [620]
Patients considering these supplements should understand that symptom relief, if experienced, may result from placebo effects or natural symptom resolution over time rather than the enzymes themselves
High protein intake stimulates postprandial GLP1 and PYY release
Int J Neurosci
